Read More 1 minute read Earnings Earnings Preview For Hologic By Benzinga Insights April 28, 2:02 PM Hologic (NASDAQ:HOLX) is set to give its latest quarterly earnings report on Monday, 2023-05-01. Here’s what investors need… HOLX
Read More 1 minute read Biotech FDA General News Court of Appeals Affirms District Court Decision Invalidating Minerva Surgical Patent Asserted Against Hologic; The U.S. Court Of Appeals Rejected Minerva’s Arguments On Appeal And As A Result, Minerva Had To Pay Hologic More Than $7.4M By Happy Mohamed February 17, 9:09 AM Hologic, Inc. (NASDAQ:HOLX) announced today that the U.S. Court of Appeals for the Federal Circuit unanimously affirmed a 2021 district court ruling that invalidated a Minerva patent asserted against Hologic. The HOLX
Read More 1 minute read Analyst Ratings News Price Target Morgan Stanley Maintains Equal-Weight on Hologic, Raises Price Target to $81 By Benzinga Newsdesk February 3, 9:25 AM Morgan Stanley analyst Tejas Savant maintains Hologic (NASDAQ:HOLX) with a Equal-Weight and raises the price target from $74 to $81. HOLX
Read More 1 minute read Analyst Ratings News Price Target Cowen & Co. Maintains Outperform on Hologic, Raises Price Target to $95 By Benzinga Newsdesk February 2, 10:50 AM Cowen & Co. analyst Max Masucci maintains Hologic (NASDAQ:HOLX) with a Outperform and raises the price target from $86 to $95. HOLX
Read More 1 minute read Analyst Ratings News Price Target JP Morgan Maintains Overweight on Hologic, Raises Price Target to $95 By Benzinga Newsdesk February 2, 10:12 AM JP Morgan analyst Casey Woodring maintains Hologic (NASDAQ:HOLX) with a Overweight and raises the price target from $90 to $95. HOLX
Read More 1 minute read Analyst Ratings News Price Target Raymond James Maintains Outperform on Hologic, Raises Price Target to $95 By Benzinga Newsdesk February 2, 7:38 AM Raymond James analyst Andrew Cooper maintains Hologic (NASDAQ:HOLX) with a Outperform and raises the price target from $80 to $95. HOLX
Read More 1 minute read Analyst Ratings News Price Target SVB Leerink Maintains Outperform on Hologic, Raises Price Target to $93 By Benzinga Newsdesk February 2, 5:38 AM SVB Leerink analyst Puneet Souda maintains Hologic (NASDAQ:HOLX) with a Outperform and raises the price target from $90 to $93. HOLX
Read More 1 minute read Analyst Ratings News Price Target Mizuho Maintains Buy on Hologic, Raises Price Target to $90 By Benzinga Newsdesk January 24, 8:42 AM Mizuho analyst Anthony Petrone maintains Hologic (NASDAQ:HOLX) with a Buy and raises the price target from $77 to $90. HOLX
Read More 1 minute read Analyst Ratings News Price Target SVB Leerink Maintains Outperform on Hologic, Raises Price Target to $90 By Benzinga Newsdesk January 12, 7:09 AM SVB Leerink analyst Puneet Souda maintains Hologic (NASDAQ:HOLX) with a Outperform and raises the price target from $85 to $90. HOLX
Read More 1 minute read Movers Trading Ideas What’s Going On With Hologic Shares Today? By Sean Torres January 9, 1:38 PM Hologic, Inc. (NASDAQ: HOLX) shares are trading higher today after the company reported preliminary first-quarter revenue results. HOLX